These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38139018)

  • 1. MELAS-Derived Neurons Functionally Improve by Mitochondrial Transfer from Highly Purified Mesenchymal Stem Cells (REC).
    Liu L; Yang J; Otani Y; Shiga T; Yamaguchi A; Oda Y; Hattori M; Goto T; Ishibashi S; Kawashima-Sonoyama Y; Ishihara T; Matsuzaki Y; Akamatsu W; Fujitani M; Taketani T
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Transfer of Wharton's Jelly Mesenchymal Stem Cells Eliminates Mutation Burden and Rescues Mitochondrial Bioenergetics in Rotenone-Stressed MELAS Fibroblasts.
    Lin TK; Chen SD; Chuang YC; Lan MY; Chuang JH; Wang PW; Hsu TY; Wang FS; Tsai MH; Huang ST; Wang XW; Tsai PC; Lin HY; Liou CW
    Oxid Med Cell Longev; 2019; 2019():9537504. PubMed ID: 31249652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles and Cx43-Gap Junction Channels Are the Main Routes for Mitochondrial Transfer from Ultra-Purified Mesenchymal Stem Cells, RECs.
    Yang J; Liu L; Oda Y; Wada K; Ago M; Matsuda S; Hattori M; Goto T; Ishibashi S; Kawashima-Sonoyama Y; Matsuzaki Y; Taketani T
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly-purified rapidly expanding clones, RECs, are superior for functional-mitochondrial transfer.
    Yang J; Liu L; Oda Y; Wada K; Ago M; Matsuda S; Hattori M; Goto T; Kawashima Y; Matsuzaki Y; Taketani T
    Stem Cell Res Ther; 2023 Mar; 14(1):40. PubMed ID: 36927781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.
    El-Hattab AW; Adesina AM; Jones J; Scaglia F
    Mol Genet Metab; 2015; 116(1-2):4-12. PubMed ID: 26095523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells.
    Bhattacharya S; Yin J; Huo W; Chaum E
    Stem Cell Res Ther; 2022 Jun; 13(1):260. PubMed ID: 35715869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming.
    Povea-Cabello S; Villanueva-Paz M; Villalón-García I; Talaverón-Rey M; Álvarez-Cordoba M; Suárez-Rivero JM; Montes MÁ; Rodríguez-Moreno A; Andrade-Talavera Y; Armengol JA; Sánchez-Alcázar JA
    Cell Reprogram; 2022 Oct; 24(5):294-303. PubMed ID: 35802497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MELAS mutation m.3243A>G promotes reactivation of fetal cardiac genes and an epithelial-mesenchymal transition-like program via dysregulation of miRNAs.
    Meseguer S; Panadero J; Navarro-González C; Villarroya M; Boutoual R; Comi GP; Armengod ME
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3022-3037. PubMed ID: 29928977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model.
    Frey S; Geffroy G; Desquiret-Dumas V; Gueguen N; Bris C; Belal S; Amati-Bonneau P; Chevrollier A; Barth M; Henrion D; Lenaers G; Bonneau D; Reynier P; Procaccio V
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):284-291. PubMed ID: 27815040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miro1 improves the exogenous engraftment efficiency and therapeutic potential of mitochondria transfer using Wharton's jelly mesenchymal stem cells.
    Lin YH; Lin KL; Wang XW; Lee JJ; Wang FS; Wang PW; Lan MY; Liou CW; Lin TK
    Mitochondrion; 2024 May; 76():101856. PubMed ID: 38408618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
    Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
    Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.
    Esterhuizen K; Lindeque JZ; Mason S; van der Westhuizen FH; Rodenburg RJ; de Laat P; Smeitink JAM; Janssen MCH; Louw R
    Metabolomics; 2021 Jan; 17(1):10. PubMed ID: 33438095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease.
    Lin DS; Huang YW; Ho CS; Hung PL; Hsu MH; Wang TJ; Wu TY; Lee TH; Huang ZD; Chang PC; Chiang MF
    Cells; 2019 Jan; 8(1):. PubMed ID: 30658448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels.
    Kodaira M; Hatakeyama H; Yuasa S; Seki T; Egashira T; Tohyama S; Kuroda Y; Tanaka A; Okata S; Hashimoto H; Kusumoto D; Kunitomi A; Takei M; Kashimura S; Suzuki T; Yozu G; Shimojima M; Motoda C; Hayashiji N; Saito Y; Goto Y; Fukuda K
    FEBS Open Bio; 2015; 5():219-25. PubMed ID: 25853038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts.
    Cotán D; Cordero MD; Garrido-Maraver J; Oropesa-Ávila M; Rodríguez-Hernández A; Gómez Izquierdo L; De la Mata M; De Miguel M; Lorite JB; Infante ER; Jackson S; Navas P; Sánchez-Alcázar JA
    FASEB J; 2011 Aug; 25(8):2669-87. PubMed ID: 21551238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells alleviate oxidative stress-induced mitochondrial dysfunction in the airways.
    Li X; Michaeloudes C; Zhang Y; Wiegman CH; Adcock IM; Lian Q; Mak JCW; Bhavsar PK; Chung KF
    J Allergy Clin Immunol; 2018 May; 141(5):1634-1645.e5. PubMed ID: 28911970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.
    Scaglia F; Northrop JL
    CNS Drugs; 2006; 20(6):443-64. PubMed ID: 16734497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myocardial infarction in a patient with MELAS syndrome: a possible link?
    Cosma J; Russo A; Schino S; Belli M; Mango R; Chiricolo G; Martuscelli E; Mariano EG
    Minerva Cardiol Angiol; 2023 Aug; 71(4):374-380. PubMed ID: 35767235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.